An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese

被引:3
作者
Jiang, Menglin [1 ,2 ]
Yang, Jin [3 ,4 ]
Yang, Linlin [5 ]
Wang, Lina [5 ]
Wang, Ting [1 ,2 ]
Han, Shengna [5 ]
Cheng, Ye [1 ,2 ]
Chen, Zihua [3 ,4 ]
Su, Yu [1 ,2 ]
Zhang, Lirong [5 ]
Yang, Fanping [3 ,4 ]
Chen, Sheng-an [3 ,4 ]
Zhang, Jin [1 ,2 ]
Xiong, Hao [3 ,4 ]
Wang, Lanting [3 ,4 ]
Zhang, Zhen [3 ,4 ]
Ma, Li [3 ,4 ]
Luo, Xiaoqun [3 ,4 ]
Xing, Qinghe [1 ,2 ]
机构
[1] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China
[2] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China
[3] Fudan Univ, Huashan Hosp, Dept Allergy & Immunol, Shanghai 200040, Peoples R China
[4] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200040, Peoples R China
[5] Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Zhengzhou 450001, Peoples R China
基金
中国国家自然科学基金;
关键词
TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME; HYPERSENSITIVITY REACTIONS; SYSTEMIC SYMPTOMS; RISK; HLA-B-ASTERISK-1301; EOSINOPHILIA; ALLOPURINOL; PEPTIDES; ALLELE;
D O I
10.1016/j.isci.2023.107391
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Levofloxacin-induced severe cutaneous adverse drug reactions (LEV-SCARs) remain unexplored. An association study of human leukocyte antigen (HLA) alleles with LEV-SCARs among 12 patients, 806 healthy subjects, and 100 levofloxacin-tolerant individuals was performed. The carrier frequencies of HLA-B*13:01 (odds ratio [OR]: 4.50; 95% confidence interval [CI]: 1.15-17.65; p = 0.043), HLA-B*13:02 (OR: 6.14; 95% CI: 1.73-21.76; p = 0.0072), and serotype B13 (OR: 17.73; 95% CI: 3.61-86.95; p = 4.85 x 10(-5)) in patients with LEV-SCARs were significantly higher than those of levofloxacin-tolerant individuals. Molecular docking analysis suggested that levofloxacin formed more stable binding models with HLA-B*13:01 and HLA-B*13:02 than with non-risk HLA-B*46:01. Mass spectrometry revealed that nonapeptides bound to HLA-B*13:02 shifted at several positions after exposure to levofloxacin. Prospective screening for serotype B13 (sensitivity: 83%, specificity: 78%) and alternative drug treatment for carriers may significantly decrease the incidence of LEV-SCARs.
引用
收藏
页数:14
相关论文
共 45 条
[31]   Quinolone antibiotics [J].
Pham, Thu D. M. ;
Ziora, Zyta M. ;
Blaskovich, Mark A. T. .
MEDCHEMCOMM, 2019, 10 (10) :1719-1739
[32]   SEVERE ADVERSE CUTANEOUS REACTIONS TO DRUGS [J].
ROUJEAU, JC ;
STERN, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1272-1285
[33]   ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis [J].
Sassolas, B. ;
Haddad, C. ;
Mockenhaupt, M. ;
Dunant, A. ;
Liss, Y. ;
Bork, K. ;
Haustein, U. F. ;
Vieluf, D. ;
Roujeau, J. C. ;
Le Louet, H. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) :60-68
[34]   HLA-B*13:01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients [J].
Satapornpong, Patompong ;
Pratoomwun, Jirawat ;
Rerknimitr, Pawinee ;
Klaewsongkram, Jettanong ;
Nakkam, Nontaya ;
Rungrotmongkol, Thanyada ;
Konyoung, Parinya ;
Saksit, Niwat ;
Mahakkanukrauh, Ajanee ;
Amornpinyo, Warayuwadee ;
Khunarkornsiri, Usanee ;
Tempark, Therdpong ;
Wantavornprasert, Kittipong ;
Jinda, Pimonpan ;
Koomdee, Napatrupron ;
Jantararoungtong, Thawinee ;
Rerkpattanapipat, Ticha ;
Wang, Chuang-Wei ;
Naisbitt, Dean ;
Tassaneeyakul, Wichittra ;
Ariyachaipanich, Manasalak ;
Roonghiranwat, Thapana ;
Pirmohamed, Munir ;
Chung, Wen-Hung ;
Sukasem, Chonlaphat .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[35]   Acute generalized exanthematous pustulosis (AGEP) - A clinical reaction pattern [J].
Sidoroff, A ;
Halevy, S ;
Bavinck, JNB ;
Vaillant, L ;
Roujeau, JC .
JOURNAL OF CUTANEOUS PATHOLOGY, 2001, 28 (03) :113-119
[36]  
Smith DA, 2006, CURR OPIN DRUG DISC, V9, P38
[37]  
Teo WL, 2010, ANN ACAD MED SINGAP, V39, P660
[38]   Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation [J].
Thomson, Paul J. ;
Illing, Patricia T. ;
Farrell, John ;
Alhaidari, Mohammad ;
Bell, Catherine C. ;
Berry, Neil ;
O'Neill, Paul M. ;
Purcell, Anthony W. ;
Park, Kevin B. ;
Naisbitt, Dean J. .
ALLERGY, 2020, 75 (03) :636-647
[39]   Severe cutaneous adverse reactions to drugs [J].
Tu Anh Duong ;
Valeyrie-Allanore, Laurence ;
Wolkenstein, Pierre ;
Chosidow, Olivier .
LANCET, 2017, 390 (10106) :1996-2011
[40]   A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome [J].
Watanabe, Hideaki ;
Watanabe, Yurie ;
Tashiro, Yasuya ;
Mushiroda, Taisei ;
Ozeki, Takeshi ;
Hashizume, Hideo ;
Sueki, Hirohiko ;
Yamamoto, Toshinori ;
Utsunomiya-Tate, Naoko ;
Gouda, Hiroaki ;
Kusakabe, Yoshio .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 88 (03) :320-329